To test the beneficial effect of IGF-I on a NASH mouse model, we administered recombinant human IGF-I for 1 month by using osmotic pump on methionine-choline-deficient diet-fed db/db mice (MCD-db/db). Here, IGF1 is linked to metabolic dysfunction-associated steatohepatitis.